The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

“And nerve impulses are produced by tiny molecular batteries ... “It is an important step forward, because it provides proof of concept that a [sodium-channel blocker] can reduce pain in ...

ROCKAWAY, N.J. - electroCore, Inc. (NASDAQ:ECOR), a bioelectronic medicine company with a market capitalization of approximately $105 million, has been granted two new patents by the United States ...